CLINICAL_TRIALS
trial_result
· 2021-07-20
Clinical Trial Update: A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis [Phase 2]
Summary
Phase 2 clinical trial update assessing safety and efficacy of DRM02 in subjects with atopic dermatitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dermira, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED